Certain cancers demonstrate clear hereditary patterns and are transmitted through specific genetic mutations within families. Genetic testing identifies individuals carrying these inherited cancer susceptibility genes, enabling early detection strategies decades before cancer typically develops.
The cancer risk panel evaluates hereditary predisposition to breast cancer (BRCA mutations), colorectal malignancies, and ovarian cancer. Individuals identified as high-risk undergo enhanced surveillance protocols, including more frequent screening examinations and advanced imaging. Early detection through intensive monitoring dramatically improves survival rates and treatment outcomes, often enabling curative interventions at earlier disease stages.